Clinical research of Ganshuang granules on cirrhotic patients following chronic hepatitis B
Phase 4
Completed
- Conditions
- hepaticsclerosis
- Registration Number
- ITMCTR2000003466
- Lead Sponsor
- The Affiliated Hospital of Northwest Minzu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Guidelines for the prevention and treatment of chronic hepatitis B (2015)
Exclusion Criteria
Hepatitis A, C or D virus infection; Immune hepatitis, drug hepatitis, steatohepatitis; Combined with severe dysfunction of heart, lung, kidney, brain or other organs; Combined with malignant tumor or mental disease.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ALT, AST, Alb, TBil, HA, C?, PCIII, LN, Th17/Treg;
- Secondary Outcome Measures
Name Time Method